Treating high-risk stomach bacteria to prevent stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether treating a specific high-risk type of H. pylori (a stomach bacteria) can lower the chance of stomach cancer. If you carry this type, you may be able to join a study group that gets treatment and is followed over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have not taken H. pylori treatment in the last month.
- You are able to provide a stool sample and have other tests as required.
- You are found to have a high-risk type of H. pylori based on a special test.
- You have never had stomach cancer or other digestive tract cancer.
- You do not have severe health conditions that would make long-term follow-up difficult.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who carry a high-risk type of Helicobacter pylori (a stomach bacteria) to see if they develop gastric cancer. It aims to understand who is most at risk and how to monitor them over time.
This trial is testing a new way to identify people at higher risk for stomach cancer using a gene test for Helicobacter pylori. It may help detect cancer early in people aged 40 and older.
This trial studies whether testing for an infection called H. pylori and using simple blood/screening tests (pepsinogen testing) can help prevent stomach cancer and reduce stomach-cancer-related deaths. You would be followed for health outcomes to see if the approach works better than standard care.
This study looks at how treating an H. pylori infection affects the health of your stomach over time. If you have this infection, the treatment may help reduce your risk of future stomach problems, including cancer.
This study looks at a screening plan to prevent stomach cancer by identifying people who should be tested and treated for H. pylori, a common stomach germ. If you have never had H. pylori testing or treatment, the trial may help determine the best approach for prevention.
This study looks at whether having H. pylori infection (a common stomach bacteria) and certain features of stomach growth can predict how early stomach cancer or pre-cancerous changes will behave and what your long-term outlook might be. You may be eligible if you are being treated with a camera-based removal procedure called endoscopic submucosal dissection (ESD).
Hear when a new Gastric (Stomach) Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.